Skip to content

Megan McMellon

Associate

London

Image of Megan McMellon
Megan McMellon

Associate

London

Related articles

Liquid dropping into test tubes in a laboratory

News: 21 September 2023

Allen & Overy has advised Exscientia on its USD674 million AI drug discovery collaboration with Merck KGaA

Collaboration will leverage Exscientia’s precision design capabilities to focus on previously unsolved drug design challenges.

Read more Allen & Overy has advised Exscientia on its USD674 million AI drug discovery collaboration with Merck KGaA

Blog Post: 04 January 2023

Why AI drug discovery deals are different from traditional pharma collaborations

Read more Why AI drug discovery deals are different from traditional pharma collaborations

Publications: 20 December 2022

Why AI drug discovery deals are different from traditional pharma collaborations

Read more Why AI drug discovery deals are different from traditional pharma collaborations

News: 07 January 2022

Allen & Overy has advised Exscientia on its USD 5.2 billion strategic research collaboration with Sanofi to develop an AI-driven pipeline of precision-engineered medicines

Read more Allen & Overy has advised Exscientia on its USD 5.2 billion strategic research collaboration with Sanofi to develop an AI-driven pipeline of precision-engineered medicines

Expertise

Practices

Commercial

Corporate and M&A

Office

London

One Bishops Square
London
E1 6AD

View office →

Qualifications

Professional

Admitted as a Solicitor (England and Wales), 2019

Academic

BA (Hons) Law and Business Studies (Qualifying Degree), First Class, University of Warwick, 2016

Postgraduate Diploma in Legal Practice, Distinction, BPP University, 2017

Certificate in IP Transactions: Law and Practice, Distinction, University College London, 2020

European Pharma Law Academy, 2022 

Pro bono

  • Volunteer Vaccinator for COVID-19 with St John Ambulance
  • Working with an A&O team to advise the Brazzaville Foundation on its Lome initiative, which is an international agreement to combat the trafficking of substandard and falsified medicines in Africa
  • Key member of the A&O team that prepared Allen & Overy’s 2019 report regarding “The Recognition and Treatment of Relationships under Hong Kong Law”, commissioned by Hong Kong’s Equal Opportunities Commission
  • Advised at Battersea Legal Advice Clinic

Published work

  • Megan McMellon (2022) "COVID-19 -the distinction between vaccines and vaccination", A&O Life Sciences Hub
  • Megan McMellon (2021) “‘Borderline’ medical devices”, A&O Life Sciences Hub
  • Megan McMellon (2021) “Life Sciences Vision – the future of the UK Life Sciences sector”, A&O Life Sciences Hub
  • Megan McMellon (2021) “Covid-19 – the UK’s vaccination programme so far”, A&O Life Sciences Hub
  • Megan McMellon (2020) “Covid-19 – the UK’s preparation for a vaccine”, A&O Life Sciences Hub
  • Megan McMellon, Zara Sproul, Jacqueline Bore, Rafi Allos, Melissa Duquemin and Eda Zhuleku (2020) “Covid-19 and the Life Sciences Sector”, Practical Law
  • Megan McMellon (2020) “Covid-19 – regulatory flexibility and the importance of collaboration in the UK”, A&O Life Sciences Hub
  • Megan McMellon (2019) “Tech collaborations – harnessing potential whilst balancing risk”, A&O Life Sciences Hub